- The first and only family of digital, breath-actuated inhalers with built-in sensors that track inhaler events and measure inspiratory flow - Digihaler® app provides patients the ability to view and ...

Teva Respiratory LLC, an affiliate of Parsippany-based Teva Pharmaceutical Industries Ltd. announced on Monday that the U.S. Food and Drug Administration (FDA) approved ArmonAir Digihaler (fluticasone ...

PHILADELPHIA, June 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the U.S. Food and Drug Administration (FDA) has accepted the Abbreviated New Drug Application (ANDA) for ...

AirDuo RespiClick and ArmonAir RespiClick are expected to be available later this year. Teva announced that the Food and Drug Administration (FDA) has approved two new breath-activated, multi-dose dry ...

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients ...

GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for ...

Vectura's partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder), in dosage strengths of 100mcg/50mcg and ...

Citigroup is nearing a deal to sell a 24% stake in its Mexican retail bank Grupo Financiero Banamex to a group of investors that includes Blackstone , Bloomberg News reported on Monday, citing people ...

Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...